Ontozry Den europeiske union - norsk - EMA (European Medicines Agency)

ontozry

angelini pharma s.p.a - cenobamate - epilepsi - antiepileptics, - adjunctive treatment of focal-onset seizures with or without secondary generalisation in adult patients with epilepsy who have not been adequately controlled despite a history of treatment with at least 2 anti-epileptic medicinal products.

Orserdu Den europeiske union - norsk - EMA (European Medicines Agency)

orserdu

stemline therapeutics b.v. - elacestrant - bryst neoplasms - endokrin terapi - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.

Feminil 2 mg / 35 mikrog Norge - norsk - Statens legemiddelverk

feminil 2 mg / 35 mikrog

sandoz - københavn - cyproteronacetat / etinyløstradiol - tablett, drasjert - 2 mg / 35 mikrog

Zyrona 2 mg / 35 mikrog Norge - norsk - Statens legemiddelverk

zyrona 2 mg / 35 mikrog

orifarm generics (3) - cyproteronacetat / etinyløstradiol - tablett, drasjert - 2 mg / 35 mikrog

Taloxa 600 mg Norge - norsk - Statens legemiddelverk

taloxa 600 mg

n.v. organon - kloosterstraat - felbamat - tablett - 600 mg